The DOI matches its Crossref record; 17 of the 17 references it cites were found in a registry or an index.
Formation of the initial C3 convertase of the alternative complement pathway. Acquisition of C3b-like activities by spontaneous hydrolysis of the putative thioester in native C3.
Open accessAbstract
Activation of the alternative pathway of complement commences with the formation of an initial fluid-phase C3 convertase. Treatment of C3 with the nucleophilic reagent methylamine has previously been shown to result in the cleavage of an intramolecular thioester bond and to induce C3b-like properties, including the ability to form a fluid-phase C3 convertase. This report examines the hypothesis that spontaneous hydrolysis of the thioester generates a derivative of C3 that is responsible for the formation of the initial C3 convertase of the alternative pathway. The rate of spontaneous decay of C3 hemolytic activity in buffer was found to be between 0.2 and 0.4%/h. In the presence of other alternative pathway proteins, the rate of inactivation was 1%/h. The rate of spontaneous inactivation was greatly accelerated by low concentrations of chaotrophic agents such as KSCN or guanidine. Liberation of a sulfhydryl group, not present in native C3, correlated with loss of hemolytic activity, indicating that exposure to chaotropic agents resulted in thioester hydrolysis. Unlike native C3, C3 bearing a single reactive sulfhydryl group was capable of generating fluid-phase C3 convertase with Factors B, D, and P and was cleaved by Factor I (C3b inactivator) in the presence of Factor H (beta 1H). The fragmentation patterns indicated that the C3a domain was covalently associated with the functionally C3b-like C3. Organomercurial agarose was employed for the rapid removal of sulfhydryl-bearing, hemolytically inactive forms of C3 and C3b from native hemolytically active C3.
Overview
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Integrity signals
Registry
Cites
Statistics
Verification
Claims the paper makes
The claims and statistics of this paper haven’t been checked yet.
Free: it reads the open-access text and checks the first 5 claims that cite a source we can check. Create a free account to check every claim.
Self-check
Percentages, sums and reported differences re-computed from the paper’s own numbers.
The self-check needs the paper’s full text.
Citations
Cites
Ellman, G. L. (1959) · Archives of Biochemistry and Biophysics · doi:10.1016/0003-9861(59)90090-6 · Cited by 26,311
Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J. (1977) · The Journal of experimental medicine · doi:10.1084/jem.146.1.257 · Cited by 684
Self-citationThird component of human complement: purification from plasma and physicochemical characterization
Tack, B. F., & Prahl, J. W. (1976) · Biochemistry · doi:10.1021/bi00665a028 · Cited by 516
Molecular Biology and Chemistry of the Alternative Pathway of Complement
Müller-Eberhard, H. J., & Schreiber, R. D. (1980) · Advances in Immunology · doi:10.1016/s0065-2776(08)60042-5 · Cited by 408
Self-citationEvidence for presence of an internal thiolester bond in third component of human complement.
Tack, B. F., Harrison, R. A., Janatova, J., Thomas, M. L., & Prahl, J. W. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.10.5764 · Cited by 370
Pangburn, M. K., & Müller-Eberhard, H. J. (1980) · The Journal of experimental medicine · doi:10.1084/jem.152.4.1102 · Cited by 334
Self-citationThe covalent-binding reaction of complement component C3
Sim, R. B., Twose, T. M., Paterson, D. S., & Sim, E. (1981) · Biochemical Journal · doi:10.1042/bj1930115 · Cited by 297
Mechanism of action of factor D of the alternative complement pathway.
Lesavre, P. H., & Müller-Eberhard, H. J. (1978) · The Journal of experimental medicine · doi:10.1084/jem.148.6.1498 · Cited by 199
Self-citationTHE REACTION MECHANISM OF HUMAN C5 IN IMMUNE HEMOLYSIS
Cooper, N. R., & Müller‐Eberhard, H. J. (1970) · The Journal of Experimental Medicine · doi:10.1084/jem.132.4.775 · Cited by 188
Self-citationCovalent binding and hemolytic activity of complement proteins.
Law, S. K., Lichtenberg, N. A., & Levine, R. P. (1980) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.77.12.7194 · Cited by 185
Cited by
Complement: a key system for immune surveillance and homeostasis
Ricklin, D., Hajishengallis, G., Yang, K., & Lambris, J. D. (2010) · Nature Immunology · doi:10.1038/ni.1923 · Cited by 3,654
“The tick-over segment keeps complement alert and allows constant probing of cell”
BackgroundComplement System Part I – Molecular Mechanisms of Activation and Regulation
Merle, N. S., Church, S. E., Fremeaux-Bacchi, V., & Roumenina, L. T. (2015) · Frontiers in Immunology · doi:10.3389/fimmu.2015.00262 · Cited by 1,620
Viral Subversion of the Immune System
Tortorella, D., Gewurz, B. E., Furman, M. H., Schust, D. J., & Ploegh, H. L. (2000) · Annual Review of Immunology · doi:10.1146/annurev.immunol.18.1.861 · Cited by 835
Structures of complement component C3 provide insights into the function and evolution of immunity
Janssen, B. J. C., Huizinga, E. G., Raaijmakers, H. C. A., Roos, A., Daha, M. R., Nilsson-Ekdahl, K., Nilsson, B., & Gros, P. (2005) · Nature · doi:10.1038/nature04005 · Cited by 541
Nath, K. A., Hostetter, M. K., & Hostetter, T. H. (1985) · Journal of Clinical Investigation · doi:10.1172/jci112020 · Cited by 495
Complement component C3 – The “Swiss Army Knife” of innate immunity and host defense
Ricklin, D., Reis, E. S., Mastellos, D. C., Gros, P., & Lambris, J. D. (2016) · Immunological Reviews · doi:10.1111/imr.12500 · Cited by 484
Complement activation, regulation, and molecular basis for complement‐related diseases
Bajic, G., Degn, S. E., Thiel, S., & Andersen, G. R. (2015) · The EMBO Journal · doi:10.15252/embj.201591881 · Cited by 374
Complement driven by conformational changes
Gros, P., Milder, F. J., & Janssen, B. J. C. (2008) · Nature Reviews Immunology · doi:10.1038/nri2231 · Cited by 323
Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J. (1983) · Proceedings of the National Academy of Sciences · doi:10.1073/pnas.80.17.5430 · Cited by 317
Self-citationThe alternative pathway of complement
Pangburn, M. K., & Müller-Eberhard, H. J. (1984) · Springer Seminars in Immunopathology · doi:10.1007/bf01893019 · Cited by 291
Self-citationMacedo, A. C. L., & Isaac, L. (2016) · Frontiers in Immunology · doi:10.3389/fimmu.2016.00055 · Cited by 290
Complement activation in amyloid plaques in Alzheimer’s dementia
Eikelenboom, P., Hack, C. E., Rozemuller, J. M., & Stam, F. C. (1988) · Virchows Archiv B Cell Pathology Including Molecular Pathology · doi:10.1007/bf02890024 · Cited by 288
Serum Bicarbonate Levels and the Progression of Kidney Disease: A Cohort Study
Shah, S. N., Abramowitz, M., Hostetter, T. H., & Melamed, M. L. (2009) · American Journal of Kidney Diseases · doi:10.1053/j.ajkd.2009.02.014 · Cited by 282
Jokiranta, T. S. (2017) · Blood · doi:10.1182/blood-2016-11-709865 · Cited by 280
Pangburn, M. K., & Müller‐Eberhard, H. J. (1983) · Annals of the New York Academy of Sciences · doi:10.1111/j.1749-6632.1983.tb18116.x · Cited by 121
Self-citationActivation of the complement system by Cryptococcus neoformans leads to binding of iC3b to the yeast
Kozel, T. R., & Pfrommer, G. S. (1986) · Infection and Immunity · doi:10.1128/iai.52.1.1-5.1986 · Cited by 102
Kozel, T. R., Wilson, M. A., & Murphy, J. W. (1991) · Infection and Immunity · doi:10.1128/iai.59.9.3101-3110.1991 · Cited by 86
Complement System Response to Adeno-Associated Virus Vector Gene Therapy
Kropf, E., Markusic, D. M., Majowicz, A., Mingozzi, F., & Kuranda, K. (2024) · Human Gene Therapy · doi:10.1089/hum.2023.194 · Cited by 39
Self versus nonself discrimination by the soluble complement regulators factor H and FHL-1
Dopler, A., Guntau, L., Harder, M. J., Palmer, A., Höchsmann, B., Schrezenmeier, H., Simmet, T., Huber-Lang, M., & Schmidt, C. Q. (2019) · The Journal of Immunology · doi:10.4049/jimmunol.1801545 · Cited by 35
Metadata
- Authors
- Pangburn, M. K., Schreiber, R. D., & Müller-Eberhard, H. J.
- Venue
- The Journal of experimental medicine
- Publisher
- Rockefeller University Press
- Published
- 1981-09-01
- Volume
- 154
- Issue
- 3
- Pages
- 856-867
- ISSN
- 0022-1007 (ISSN-L)
- 1540-9538
- OpenAlex
- W2097222143
- Cited by
- 446
- References
- 17
- FWCI
- 5.24
- Type
- journal article
- Language
- en
- Open access
- bronze
About these checks
Registry, retraction, Cites and statistics results are computed, not judged, with one exception: a printed reference that no index lists is read once by a model before it counts as a citation error. Claims are extracted by a model and kept only when their quote appears verbatim in the text; each cited source is then checked, with a model’s help, for whether it says what the claim relies on. Those verdicts can be wrong — read the claim’s quote and the cited source before relying on one.
Statistics and arithmetic are recomputed, not judged.
Confidence bands are shown only for fields calibrated on our annotated test set. None is calibrated yet, so no band is shown.
What counts as a claim ›How we measure confidence ›How we check this ›
Are you an author, or do you see a problem with this page? Request a review
Data sources
Bibliographic data: Semantic Scholar, OpenAlex, Crossref.
Contains information from the Semantic Scholar Academic Graph Datasets, made available under the ODC Attribution License (ODC-BY 1.0).
Semantic Scholar’s data is described in: Kinney, R., et al. (2023). The Semantic Scholar Open Data Platform. arXiv:2301.10140.